Drug Trial Radar · NCT07219602
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Dec 11, 2025
Primary completion
Mar 2028
Study completion Jun 2028
Sponsor
- Lead sponsor
- NewAmsterdam PharmaIndustry
- Sponsor type
- Industry
- First posted
- Oct 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be a placebo-controlled, double-blind, randomized, Phase 3 study to evaluate the efficacy, safety, and tolerability of obicetrapib 10 mg, both as a fixed-dose combination (FDC) with ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering therapy in patients with metabolic syndrome and/or Type 2 Diabetes Mellitus.
Conditions
- Lipidemia
- Type 2 Diabetes (T2DM)
- Metabolic Syndrome (MetS)
Interventions
obicetrapib 10 mg + ezetimibe 10 mg FDC dailyDrug
FDC
Obicetrapib 10 mgDrug
monotherapy
PlaceboOther
placebo on top of guideline-recommended lipid modifying therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- The percent change from Baseline to Day 84 in LDL-C compared with placebo for the following treatment groups: - obicetrapib 10 mg + ezetimibe 10 mg FDC treatment group; and - obicetrapib 10 mg monotherapy treatment groupTime frame: 84 days
Locations
55 sites in 4 countries. Site status is shown where the registry gives one.
Clinical Research Institute of Arizona
Sun City West, Arizona
Scripps Health - Whittier Diabetes Institute
La Jolla, California
UC SanDiego Health
La Jolla, California
Western University of Health Sciences
Pomona, California
UF Health Jackson
Jacksonville, Florida
East Coast Institute of Research LLC
Jacksonville, Florida
East Coast Institute of Research LLC
Lake City, Florida
K2 Medical Research
Maitland, Florida
Floridian Clinical Research
Miami Lakes, Florida
Cardiovascular Center of Sarasote Foundation for Research and Education
Sarasota, Florida
High Desert Heart
Meridian, Idaho
Endeavour Health
Skokie, Illinois
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
Louisville, Kentucky
Eastern Maine Medical Center
Bangor, Maine
MD Medical Research
Oxon Hill, Maryland
Jefferson City Medical Group
Jefferson City, Missouri
Montana Medical Research
Missoula, Montana
Inspira Health - Internal Medicine Associates
Bridgeton, New Jersey
Central New York Clinical Research
Manlius, New York
Duke University Medical Center
Durham, North Carolina
Velocity Clinical Research
Durham, North Carolina
PharmQuest Life Sciences, LLC
Greensboro, North Carolina
Centricity Research dba Lucas Research
Morehead City, North Carolina
Summit Research Group
Munroe Falls, Ohio
Diabetes & Glandular Disease Clinic, P.A.
Kingsport, Tennessee
Baylor College of Medicine - Center for Cardiometabolic Disease Prevention (The Center for Cardiovascular Disease Prevention)
Houston, Texas
Juno Research LLC - Medical Center
Houston, Texas
PlanIt Research, PLLC
Houston, Texas
Clinical Trials of Texas dba Flourish Research
San Antonio, Texas
Burke Internal Medicine
Burke, Virginia
Burke International Medicine DBA Manassas Clinical Research Center
Manassas, Virginia
Universal Research Group
Tacoma, Washington
DOCTOR MN s.r.o
Čáslav, Czechia
MUDr. Alena Váchová
České Budějovice, Czechia
MEDIKA Hradec Králové, s.r.o.
Hradec Králové, Czechia
Interni diabetologicka ambulance (Pratia)
Jílové u Prahy, Czechia
Diabetologie - Dr. Tomas Edelsberger
Krnov, Czechia
Pratia Pardubice a.s. (Pratia)
Pardubice, Czechia
Dieko s.r.o
Pilsen, Czechia
Nemocnice Na Františku
Prague, Czechia
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.